期刊文献+

小干扰 RNA 表达质粒沉默△Np73 对人乳腺癌细胞 MDA-MB-231增殖和凋亡的影响 被引量:2

Effects of small interfering RNA expression plasmids silencing △Np73 on human breast cancer cell stain MDA-MB-231 proliferation and apoptosis
下载PDF
导出
摘要 目的:探讨靶向△Np73的小干扰RNA表达质粒转染人乳腺癌细胞株MDA-MB-231对其增殖和凋亡活性的影响。方法:构建△Np73小干扰表达质粒,脂质体法转染人乳腺癌细胞株MDA-MB-231;荧光显微镜下观察转染细胞绿色荧光蛋白表达,计算转染效率;实时荧光定量PCR检测细胞转染质粒后△Np73和TAp73 mRNA的表达;共转染pcDNA3-HA/DNp73α表达质粒与△Np73小干扰质粒,Western blot检测细胞转染后△Np73和TAp73表达;CCK-8法检测转染质粒后细胞生长抑制率;caspase 3活性分光光度法检测转染质粒并应用阿霉素处理后细胞的凋亡水平。结果:成功构建并转染△Np73小干扰表达质粒,转染效率达60%。△Np73小干扰质粒转染细胞能有效抑制内源性△Np73 mRNA和外源性△Np73蛋白表达,对TAp73无显著抑制作用。经△Np73质粒干扰的细胞增殖活性显著下降,与空白对照组相比差异显著,阿霉素诱导△Np73质粒转染细胞凋亡水平增加,与阴性对照组相比有显著差异。结论:△Np73小干扰RNA表达质粒能显著降低MDA-MB-231细胞中△Np73 mRNA及蛋白的表达,抑制细胞生长增殖,增强其被阿霉素诱导的凋亡水平,表明靶向沉默△Np73可能为未来人乳腺癌的治疗提供了一个新的策略。 Objective:To investigate the effectiveness of human breast cancer cell line MDA-MB-231 proliferation and apopto- sis activity to △Np73 small interfering RNA expression plasmid transfection. Methods: △Np73 small interfering expression plasmids were constructed and transfected into human breast cancer cell line MDA-MB-231. Transfection efficiency was calculated by counting green fluorescent protein expressing cells under fluorescence microscope. △Np73 and TAp73 mRNA expression was measured by real- time PCR. After pcDNA3-HA/DNp73cr expression plasmids were co-transfected with △Np73 small interfering plasmid, Western blot test was used to detect △Np73 and TAp73 expression level. Cell growth inhibition rate was detected by CCK-8 assay. Caspase-3 activi- ty spectrophotometry of A Np73 transfeeted and doxorubiein treated cells was examined to determine its apoptosis level. Results: △Np73 small interfering expression plasmids were successfully constructed and transfeetion efficiency reached 60%. △Np73 siRNA plasmid transfeetion effectively inhibited endogeneous △Np73 mRNA expression and exogenous △Np73 protein expression, showing no significant inhibitory effects on TAp73 mRNA and protein expression. △Np73 siRNA plasmid transfection significantly decreased pro- liferative activity of MDA-MB-231 compared with blank control group. △Np73 siRNA plasmid transfeetion apparently increased doxo- rubicin-induced apoptosis level of MDA-MB-231, with significantly difference from negative control group. Conclusion: △Np73 siRNA expression plasmids can significantly down-regulate △Np73 mRNA and protein expression in MDA-MB-231 cells, inhibit cell growth and proliferation, enhance its level of apoptosis induced by doxorubicin, indicating that targeted silencing △Np73 is likely a hopeful strategy for treatment of breast cancer in the future.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2014年第3期312-317,共6页 Chinese Journal of Immunology
基金 辽宁省自然科学基金资助(2011010179-401)
关键词 △Np73 MDA-MB-231 RNA干扰 基因沉默 乳腺癌 △Np73 MDA-MB-231 RNA interference Gene silencing Breast cancer
  • 相关文献

参考文献29

  • 1Zaika AI, Kovalev S, Marchenko ND, et al. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines [J]. Cancer Res,1999,59(13): 3257-3263.
  • 2Bozzetti C, Nizzoli R, Musolino A, et al. p73 and p53 pathway in human breast cancers [J]. J Clin Oncol, 2007, 25 (11): 1451-1453.
  • 3Zaika AI, Slade N,Erster SH,et al, DeltaNp73, a dominant-negative inhihitor of wild-type p53 and TAp73, is up-regulated in human tumors[J]. J Exp Med, 2002,196 (6) :765-780.
  • 4Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1 p36, a region frequently deleted in neuroblastoma and other human cancers [J]. Cell, 1997 , 90 ( 4 ) : 809-819.
  • 5Melino G, De Laurenzi V, Vousden KH. p 73: Friend or foe in tumorigenesis [J]. Nat Rev Cancer,2002,2(8): 605-615.
  • 6Stiewe T, Theseling CC, Putzer BM, Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis [J]. J BioI Chern, 2002,277 ( 16) : 14177-14185.
  • 7Tannapfel A, John K, Mise N , et al, Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73 [J]. Carcinogenesis, 2008,29(1) :211-218.
  • 8Buhlmann S, Putzer BM. DNp73 a matter of cancer: mechanisms and clinical implications [J]. Biochim Biophys Acta, 2008,1785 (2) :207-216.
  • 9Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2 ·Mel method [J]. Methods, 2001,25(4) :402408.
  • 10Van Gele M, Kaghad M, Leonard JH,et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma [J]. Br J Cancer, 2000, 82 (4) :823-826.

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部